Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia

NCT03422640 is registered in ClinicalTrials.gov with Bellevue Dermatology as lead sponsor.

NCT NCT03422640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03422640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia
Lead sponsor
Bellevue Dermatology
Phase
Phase 4
Overall status
Unknown status
Start date
July 12, 2018
Completion date
January 31, 2019
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frontal fibrosing alopecia